Gabapentin for Alcohol Relapse Prevention

• Status: Completed
• Trial end date: 2018-08-27
• Target enrollment: 0
• Participant gender: All

Summary

This treatment study is a 16-weeks outpatient clinical trial where subjects with alcohol dependence will get medication, which might help them to reduce or stop their drinking, or a placebo ( placebo is a capsule that looks the same as the investigational drug, but has no real medication. It is a "sugar pill").

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of South Carolina
• Treatments: Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

1. Meets criteria for alcohol use disorder based on DSM-5 criteria

2. Meets criteria for history of alcohol withdrawal based on DSM-5 criteria

3. Able to maintain abstinence for a minimum of 3 days prior to randomization as verified by self report, urine ETG, and breathalyzer.

Exclusion Criteria:

1. Significant psychiatric or medical illness

2. No other substance abuse

3. Taking other medications known to treat alcohol use disorder

4. Unstable living arrangements

5. Significant legal problems pending